rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2010-3-19
|
pubmed:abstractText |
To date no study to our knowledge has compared cancer control outcomes of segmental ureterectomy relative to nephroureterectomy, which represents the standard of care for ureteral transitional cell carcinoma. We compared cancer specific mortality rates according to surgery type (nephroureterectomy vs segmental ureterectomy) in a large population based cohort of patients with ureteral transitional cell carcinoma.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1527-3792
|
pubmed:author |
pubmed-author:BudausLarsL,
pubmed-author:GraefenMarkusM,
pubmed-author:IsbarnHendrikH,
pubmed-author:JeldresClaudioC,
pubmed-author:KarakiewiczPierre IPI,
pubmed-author:LattoufJean-BaptisteJB,
pubmed-author:LughezzaniGiovanniG,
pubmed-author:MontorsiFrancescoF,
pubmed-author:PerrottePaulP,
pubmed-author:ShariatShahrokh FSF,
pubmed-author:SunMaxineM,
pubmed-author:WidmerHuguesH
|
pubmed:copyrightInfo |
Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
183
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1324-9
|
pubmed:meshHeading |
pubmed-meshheading:20171666-Adult,
pubmed-meshheading:20171666-Aged,
pubmed-meshheading:20171666-Aged, 80 and over,
pubmed-meshheading:20171666-Carcinoma, Transitional Cell,
pubmed-meshheading:20171666-Female,
pubmed-meshheading:20171666-Humans,
pubmed-meshheading:20171666-Male,
pubmed-meshheading:20171666-Middle Aged,
pubmed-meshheading:20171666-Nephrectomy,
pubmed-meshheading:20171666-Retrospective Studies,
pubmed-meshheading:20171666-Ureter,
pubmed-meshheading:20171666-Ureteral Neoplasms,
pubmed-meshheading:20171666-Urologic Surgical Procedures
|
pubmed:year |
2010
|
pubmed:articleTitle |
Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter.
|
pubmed:affiliation |
Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|